The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Protection against acetaminophen-induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase
Abstract
Mechanistic study of idiosyncratic drug-induced hepatitis (DIH) continues to be a challenging problem because of the lack of animal models. The inability to produce this type of hepatotoxicity in animals, and its relative rarity in humans, may be linked to the production of anti-inflammatory factors that prevent drug-protein adducts from causing liver injury by immune and nonimmune mechanisms. We tested this hypothesis by using a model of acetaminophen (APAP)-induced liver injury in mice. After APAP treatment, a significant increase was observed in serum levels of interleukin (IL)-4, IL-10, and IL-13, cytokines that regulate inflammatory mediator production and cell-mediated autoimmunity. When IL-10 knockout (KO) mice were treated with APAP, most of these mice died within 24 to 48 hours from liver injury. This increased susceptibility to APAP-induced liver injury appeared to correlate with an elevated expression of liver proinflammatory cytokines, tumor necrosis factor (TNF)-α, and IL-1, as well as inducible nitric oxide synthase (iNOS). In this regard, mice lacking both IL-10 and iNOS genes were protected from APAP-induced liver injury and lethality when compared with IL-10 KO mice. All strains, including wild-type animals, generated similar amounts of liver APAP-protein adducts, indicating that the increased susceptibility of IL-10 KO mice to APAP hepatotoxicity was not caused by an enhanced formation of APAP-protein adducts. In conclusion, these findings suggest that an important feature of the normal response to drug-induced liver injury may be the increased expression of anti-inflammatory factors such as IL-10. Certain polymorphisms of these factors may have a role in determining the susceptibility of individuals to idiosyncratic DIH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758
Geller, D. A., Nussler, A. K., Di Silvio, M., Lowenstein, C. J., Shapiro, R. A., Wang, S. C., Simmons, R. L., & Billiar, T. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.522 · Cited by 665
Local control of the immune response in the liver
Knolle, P. A., & Gerken, G. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017408.x · Cited by 603
Portmann, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80245-6 · Cited by 549
Lee, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292508 · Cited by 546
Zimmerman, H. J., & Maddrey, W. C. (1995) · Hepatology · doi:10.1002/hep.1840220312 · Cited by 460
Microsomal Ethanol‐Oxidizing System (MEOS): The First 30 Years (1968‐1998)–A Review
Lieber, C. S. (1999) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04217.x · Cited by 426
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
ACETAMINOPHEN-INDUCED HEPATOTOXICITY
James, L. P., Mayeux, P. R., & Hinson, J. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.12.1499 · Cited by 1,033
Mechanisms of Acetaminophen-Induced Liver Necrosis
Hinson, J. A., Roberts, D. W., & James, L. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00663-0_12 · Cited by 1,006
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Jaeschke, H., McGill, M. R., & Ramachandran, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.602688 · Cited by 964
The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis
Hirayama, D., Iida, T., & Nakase, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010092 · Cited by 927
Macrophages and Tissue Injury: Agents of Defense or Destruction?
Laskin, D. L., Sunil, V. R., Gardner, C. R., & Laskin, J. D. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105812 · Cited by 604
Ju, C., & Tacke, F. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.104 · Cited by 554
Intracellular Signaling Mechanisms of Acetaminophen-Induced Liver Cell Death
Jaeschke, H., & Bajt, M. L. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfi336 · Cited by 529
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
Su, G. L. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00550.2001 · Cited by 480
Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity
Jaeschke, H., Williams, C. D., Ramachandran, A., & Bajt, M. L. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02501.x · Cited by 478
C-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity
Gunawan, B. K., Liu, Z., Han, D., Hanawa, N., Gaarde, W. A., & Kaplowitz, N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.045 · Cited by 471
The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity
Jaeschke, H. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00239-x · Cited by 442
Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure
Woolbright, B. L., & Jaeschke, H. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.017 · Cited by 390
The importance of immune dysfunction in determining outcome in acute liver failure
Antoniades, C. G., Berry, P. A., Wendon, J. A., & Vergani, D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.009 · Cited by 367
The Nrf2–Keap1 defence pathway: Role in protection against drug-induced toxicity
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2008) · Toxicology · doi:10.1016/j.tox.2007.10.029 · Cited by 329
Mechanisms of drug-induced liver injury
Holt, M. P., & Ju, C. (2006) · The AAPS Journal · doi:10.1208/aapsj080106 · Cited by 328
Liu, Z.-X., Govindarajan, S., & Kaplowitz, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.053 · Cited by 328
Ramachandran, A., & Jaeschke, H. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1679919 · Cited by 326
Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice
Masubuchi, Y., Suda, C., & Horie, T. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.015 · Cited by 317
Self-citationLiver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307
Idiosyncratic Drug Reactions: Current Understanding
Uetrecht, J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105150 · Cited by 304
Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of Forces
Laskin, D. L. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900086v · Cited by 287
Drug-induced liver injury: Summary of a single topic clinical research conference
Watkins, P. B., & Seeff, L. B. (2006) · Hepatology · doi:10.1002/hep.21095 · Cited by 279
Saito, C., Lemasters, J. J., & Jaeschke, H. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.04.015 · Cited by 269
Nitric oxide in gastrointestinal health and disease
Shah, V., Lyford, G., Gores, G., & Farrugia, G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.046 · Cited by 267
Functional Role of Monocytes and Macrophages for the Inflammatory Response in Acute Liver Injury
Zimmermann, H. W., Trautwein, C., & Tacke, F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00056 · Cited by 262
Abdelmegeed, M. A., Jang, S., Banerjee, A., Hardwick, J. P., & Song, B.-J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.018 · Cited by 85
Shoda, L. K. M., Woodhead, J. L., Siler, S. Q., Watkins, P. B., & Howell, B. A. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1878 · Cited by 75
Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine
Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65
Macrophages as a Cell-Based Therapy for Liver Disease
Starkey Lewis, P. J., Moroni, F., & Forbes, S. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688502 · Cited by 36
Investigating acetaminophen hepatotoxicity in multi-cellular organotypic liver models
Orbach, S. M., Cassin, M. E., Ehrich, M. F., & Rajagopalan, P. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.03.008 · Cited by 28
Metadata
- Authors
- Bourdi, M., Masubuchi, Y., Reilly, T. P., Amouzadeh, H. R., Martin, J. L., George, J. W., Shah, A. G., & Pohl, L. R.
- Venue
- Hepatology
- Published
- 2002-02
- Volume
- 35
- Issue
- 2
- Pages
- 289-298
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2009609856
- Cited by
- 302
- References
- 51
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.